Compare Hasbro, Inc. (HAS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hasbro, Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Hasbro, Inc. trades at $98 (market cap $13.46B), while Vir Biotechnology Inc. Common Stock trades at $10.51 (market cap $1.76B). The key difference: Hasbro, Inc. is far larger — about 7.6× Vir Biotechnology Inc. Common Stock's market cap, and Hasbro, Inc. pays a 2.93% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hasbro, Inc. for 97 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| HAS | VIR | |
|---|---|---|
Market Cap | $13.46B | $1.76B |
Volume | 1,300,226 | 2,764,948 |
Sector | Consumer Cyclical | Health |
52-Week High | $105.88 | $11.78 |
52-Week Low | $74.13 | $5.12 |
Typical Hold Time | 97 Days | 0 Days |
Enterprise Value | $15.65B | $1.32B |
Dividend Yield | 2.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hasbro (HAS) trades at $95.94, up 1.28% with strong technical momentum and bullish analyst sentiment. The stock shows robust earnings beats in recent quarters with Q3 2026 results expected October 20. Fundamentals reveal mixed performance with negative 2025 net income but strong 2026 projections of $794M profit. Valuation metrics include P/E of 16.99 and P/S of 2.72, while institutional activity shows recent position adjustments.
Outlook remains positive with consensus price target of $107.60 (12% upside) and no sell ratings among 33 analysts. Key catalysts include Q3 earnings and continued gaming segment growth, though risks include debt levels at 59.09% of assets and competitive pressures in consumer discretionary sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hasbro, Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
